Alicia Bigica
Editorial Director at NeurologyLive
Editorial Director at Diagnostic Imaging
Editorial Director at CGTLive
Writer, editor, science enthusiast. Editorial Director @Neurology_Live, @CGT_Live, @DX_Imaging, @Contagion_Live, and @IJMSC_Tweets at @MJHLifeScienes
Articles
-
1 month ago |
spectroscopyonline.com | Alicia Bigica
Researchers are exploring innovative strategies to combat growing antibiotic resistance. One promising approach involves the use of engineered magnetic particles to physically disrupt and eradicate persistent bacterial biofilms. These complex microbial communities, held together by a matrix of sugars, DNA, and proteins, can shield bacteria from the effects of antimicrobials, allowing them to thrive even in the presence of treatment.
-
2 months ago |
biopharminternational.com | Alicia Bigica
World Cancer Day is recognized annually on February 4th; a day to remember those lost, celebrate battles won, and shine a light on innovation and advancements that will change the future of cancer care. Cancer continues to lead the way in terms of investment in biotech, helping fund and drive new innovation at the earliest stages of development.
-
May 17, 2024 |
pharmtech.com | Alicia Bigica
At INTERPHEX 2024, Pharmaceutical Technology sat down with Melissa Green, head of global marketing, healthcare division, at TekniPlex, to discuss the company's offerings and recent additions to its capabilities. TekniPlex is a global, integrated company that provides materials science and manufacturing technology solutions for healthcare, including the medical device, pharmaceutical, and diagnostics industries.
-
Apr 23, 2024 |
biopharminternational.com | Alicia Bigica
Editor's note: this interview was originally published on PharmTech.com.
-
Apr 22, 2024 |
biopharminternational.com | Alicia Bigica
Published on: BioPharm International sat down with Christa Myers of CRB Group and Nadiyra Walker Speight of Fujifilm Diosynth Biotechnologies at INTERPHEX 2024 to examine the implementation of Annex 1. Editor's Note: This interview was originally published on PharmTech.com. Compliance with the European Union's Annex 1 updated guidance on the manufacture of sterile products is imperative for industry working within the EU or servicing EU-based clients.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 722
- Tweets
- 4K
- DMs Open
- No
Check out the latest episode of Behind the Headlines, featuring updates on GLP-1 medication availability, RNA editing success, and more: https://t.co/Aj6ctBRqWg https://t.co/b9vp1reqpK
RT @CannabisSciTech: Reports suggest that the DEA is set to reclassify cannabis from Schedule I to Schedule III! This groundbreaking move i…
.@IJMSCtweets is MORE than just peer-reviewed #MS research. Take a look behind the curtain with us and meet the authors behind some of our most-read articles in 2023 and learn more about the topics they chose to focus on. #Bestof2023 @mscare https://t.co/2CqmSVKPyJ
